MedPath

A randomized study of an internet-based cognitive behavioral therapy program for sexuality and intimacy problems in women treated for breast cancer.

Phase 3
Recruiting
Conditions
problems with sexuality and intimacy
Sexual dysfunctions and intimacy problems
10006291
10040480
Registration Number
NL-OMON40346
Lead Sponsor
Antoni van Leeuwenhoek Ziekenhuis
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Not specified
Target Recruitment
240
Inclusion Criteria

The study sample will be composed of 160 women, between 18 and 65 years of age, with histologically confirmed breast cancer, who received treatment in one of the participating hospitals. All women will have completed treatment (with the exception of endocrine therapy), received their diagnosis between 6 months and 5 years prior to study entry, and will be disease-free at time of study entry. Potentially eligible women will be screened for the presence of sexuality and intimacy problems.

Exclusion Criteria

Women will be excluded from the study if they: lack basic proficiency in Dutch; do not have access to the internet; exhibit serious cognitive or psychiatric problems (i.e. major depression, alcohol dependency, or psychotic disorders); report severe relationship problems for which the internet-based program is not designed (and which need to be addressed prior to undergoing sex therapy); are participating in a concurrent therapy program to alleviate their sexuality/intimacy problems; or have been treated for another type of cancer besides breast cancer (with the exception of cervical carcinoma in situ and basal cell carcinoma).

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>The primary study outcomes are sexuality problems, as assessed with the Sexual<br /><br>Activity Questionnaire (SAQ), the Female Sexual Dysfunction Index (FSFI), and<br /><br>the Female Sexual Distress Scale (FSDS), and intimacy problems, as assessed<br /><br>with the PAIR Inventory. </p><br>
Secondary Outcome Measures
NameTimeMethod
<p>The secondary study outcomes are body image (QLQ-BR23), menopausal symptoms<br /><br>(FACT-ES), marital functioning (MMQ), psychological distress (HADS), and health<br /><br>related quality of life (MOS SF-36). </p><br>
© Copyright 2025. All Rights Reserved by MedPath